Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous ethinylestradiol/levonorgestrel vs vitamin E for menstrually related migraine
2018-004096-12Phase 3Active
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in migraine comparing Continuous ethinylestradiol/levonorgestrel with Vitamin E (2 arms). Primary endpoint: Number of monthly migraine days. Started Apr 2019; status: active.
02
Drugs
ethinylestradiol + levonorgestrelvitamin e
03
Conditions
migraine
Beyond the preview
Go deeper on 2018-004096-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004096-12.